Czech Republic to acquire anti-Covid drug Regeneron
The Czech Republic will acquire 12,000 doses of the drug Regeneron used to treat people who are at high risk of being hospitalized with Covid-19. Prime Minister Andrej Babiš made the announcement on Twitter on Saturday, adding that the first 4,000 doses should arrive in March.
The antibody cocktail, produced by the American company Regeneron, has was found effective in preventing COVID-19 in people exposed to those infected with the new coronavirus.
The government has already secured the drug Bamlan, which works on the same principle as Regeneron. Its first delivery should arrive by the end of February. Both therapies are still being reviewed by the European Medicines Agency, but their use has been recommended by the Czech Health Ministry.